JJP Biologics

JJP Biologics sp. z o.o. is a biotechnology company specializing in the development of proprietary biologics and companion diagnostic devices to enable personalized treatment. JJP Biologics is committed to developing its own candidate products as well as projects executed in collaboration with scientific partners. The company’s projects target general immune pathways in autoimmune diseases and cancer. JJP Biologics currently has multiple projects, including the advanced JJP-1212 project and the anti-CD270 project for immuno-oncology.